Bronchial Thermoplasty in Patients with Severe Uncontrolled Asthma: First Korean Cases

다국어 초록 (Multilingual Abstract)

Bronchial thermoplasty is a nonpharmacological treatment for severe asthma that delivers thermal energy to the bronchial walls and reduces hypertrophied smooth muscle mass.
Previous studies have shown its efficacy and safety, resulting in approval from the Food and Drug Administration in 2010. In Korea, the first bronchial thermoplasty was carried out in 2014; 4 patients have undergone the procedure so far. This case series presents the medical history and treatment outcomes of these 4 patients. All patients presented with uncontrolled asthma despite optimal medical treatment. Bronchial thermoplasty was performed at the right lower lobe, left lower lobe, and both upper lobes in order at 3-week intervals. All procedures were performed under general anesthesia. Two patients had significant decreases in exacerbations and required a lower dose of inhaled corticosteroids after the procedure. One patient had slightly fewer exacerbations but failed to reduce the use of systemic corticosteroids. One patient had no change in symptoms. One limitation of bronchial thermoplasty is the difficulty of predicting clinical responders. However, since more therapeutic options are needed in the management of severe asthma, especially T2-low asthma, discussion with experts about the feasibility and necessity of bronchial thermoplasty will ensure the best possible care.

참고문헌 (Reference)

1 Zeiger RS, "Utilization and costs of severe uncontrolled asthma in a managed-care setting" 4 (4): 120-129.e3, 2016

2 Pavord ID, "Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma" 176 (176): 1185-1191, 2007

3 Castro M, "Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts : results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials" 3 (3): 355-366, 2015

4 Busse W, "Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma" 108 (108): 184-190, 2001

5 Ortega HG, "Mepolizumab treatment in patients with severe eosinophilic asthma" 371 (371): 1198-1207, 2014

6 Global Initiative for Asthma, "Global Strategy for Asthma Management and Prevention" Global Initiative for Asthma 2018

7 Castro M, "Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma : a multicenter, randomized, double-blind, sham-controlled clinical trial" 181 (181): 116-124, 2010

8 Langton D, "Bronchodilator responsiveness as a predictor of success for bronchial thermoplasty" 24 (24): 63-67, 2019

9 Benedetti PA, "Bronchial thermoplasty in patients with very severe asthma: safety and clinical outcomes" 48 : PA3839-, 2016

10 Torrego A, "Bronchial thermoplasty for moderate or severe persistent asthma in adults" (3) : CD009910-, 2014

11 Cox G, "Bronchial thermoplasty for asthma" 173 (173): 965-969, 2006

12 Wechsler ME, "Bronchial thermoplasty : long-term safety and effectiveness in patients with severe persistent asthma" 132 (132): 1295-1302, 2013

13 Langton D, "Bronchial thermoplasty : activations predict response" 18 (18): 134-, 2017

14 Dombret MC, "Bronchial thermoplasty : a new therapeutic option for the treatment of severe, uncontrolled asthma in adults" 23 (23): 510-518, 2014

15 Antonicelli L, "Asthma severity and medical resource utilisation" 23 (23): 723-729, 2004

16 Cox G, "Asthma control during the year after bronchial thermoplasty" 356 (356): 1327-1337, 2007

17 최대기, "Application of Ventilating-Bronchoscopy-Adaptor by Fusing a Laparoscopic Trocar during Bronchial Thermoplasty under General Anesthesia" 연세대학교의과대학 57 (57): 534-535, 2016

18 Han X, "A successful bronchial thermoplasty procedure in a “very severe” asthma patient with rare complications: a case report" 1-4, 2018